Table 1.
Baseline risk factor prevalence and AMI incidence rates by HIV status among included cohort studies (n=16)
| Author (year) | Smoker (%) | Dyslipidemia (%) |
Hypertension (%) |
Diabetes (%) |
AIDS (%) |
ART (%) |
IR per 1000 PY (95% CI) |
|---|---|---|---|---|---|---|---|
| HIV-infected arms | |||||||
| Althoff (2015) | 68.0 | 34.0 | 22.0 | 14.0 | 25.0 | 45.0 | 2.0 (1.8, 2.3) |
| Bedimo (2011) | 29.0 | 26.0 | 38.0 | 13.0 | 75.0 | 3.7 (2.3, 4.2) | |
| Durand (2011) | 38.1 | 23.9 | 6.6 | 31.1 | 76.2 | 3.9 (3.3, 4.6) | |
| Hasse 2011 | 23.8 | 12.7 | 56.3 | 4.1 | 23.2 | 85.0 | 2.4 (1.9, 3.2) |
| Holmberg (2002) | 56.5 | 27.9 | 11 | 4.5 | 1.19 (0.8, 1.8) | ||
| Rasmussen (2015) | 65.7 | 3.5 | 2.9 | 21.7 | 77.2 | 5.2 (4.3, 6.4) | |
| Sabin (2013) | 54.8 | 38.4 | 9.2 | 2.9 | 23.2 | 3.2 (3.0, 3.4) | |
| Silverberg (2014) | 43.3 | 5.0 | 7.3 | 2.9 | 39.4 | 46.2 | 2.8 (2.5, 3.2) |
| Triant (2007) | 23.3 | 21.2 | 11.5 | 11.1 (9.6, 12.7) | |||
| Escaut (2003) | 36.1 | 85.5 | 5.2 (3.0, 8.4) | ||||
| Rickerts (2000) | 40 | 25.7 | 1.8 (1.2, 2.5) | ||||
| Lang (2010) | 1.2 (1.1, 1.4) | ||||||
| Kwong (2006) | 40.3 | 2.01 | 1.08 | 100 | 1.2 (1.0, 1.5) | ||
| Brothers (2009) | 2.1 (0.8, 5.7) | ||||||
| Brouwer (2014) | 5.9 (4.3, 8.2) | ||||||
| Ribaudo (2011) | 38.0 | 12.0 | 18.0 | 4.0 | 19.0 | 2.1 (1.5, 2.8) | |
| HIV-uninfected arms | |||||||
| Althoff (2015) | 65.0 | 38.0 | 32.0 | 21.0 | 1.3 (1.2, 1.4) | ||
| Durand (2011) | 12.3 | 15.1 | 4.7 | 0.0 | 0.0 | 2.2 (1.9, 2.5) | |
| Rasmussen (2015) | 53.9 | 3.0 | 1.3 | 0.0 | 0.0 | 2.0 (1.7, 2.4) | |
| Triant (2007) | 17.6 | 15.9 | 6.6 | 0.0 | 0.0 | 7.0 (6.9, 7.1) |